Evidence map›Paper›PMID 26885542›Full record

ArticleOpen forum infectious diseases2016

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis.

Susanna K Tan, Elizabeth B Burgener, Jesse J Waggoner, Kiran Gajurel, Sarah Gonzalez, Sharon F Chen, Benjamin A Pinsky

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and Standardization.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  6. Article
  7. Article
  8. Delayed Onset of COVID-19 in an Immunosuppressed Patient.Infectious diseases in clinical practice (Baltimore, Md.) · 2021
    Article
  9. Review
  10. A rare case of cytomegalovirus causing respiratory failure and a large pericardial effusion.Journal of community hospital internal medicine perspectives · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Detection ofJournal of clinical and diagnostic research : JCDR · 2017
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Susanna K TanDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine.
Elizabeth B BurgenerDepartment of Pediatrics, Division of Pulmonary Medicine.
Jesse J WaggonerDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine.
Kiran GajurelDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine.
Sarah GonzalezDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Sharon F ChenDepartment of Pediatrics, Division of Infectious Diseases.
Benjamin A PinskyDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine; Department of Pathology, Stanford University School of Medicine, Stanford, California.
Stanford University · USOffice of Infectious Diseases · USPulmonary Associates · US

Funding

EMERGING INFECTIOUS DISEASEST32AI007502 · NIAID · STANFORD UNIVERSITY · PI Prasanna Jagannathan, DAVID A. RELMAN · 1995 to 2026
$6.8M
Once Bitten: Detecting the World???s Most Common Vector-Borne PathogensK08AI110528 · NIAID · STANFORD UNIVERSITY · PI WAGGONER, JESSE · 2014 to 2018
$917k
NIAID NIH HHS K08 AI110528NIAID NIH HHS T32 AI007502
6 · The paper itself

Abstract

Background.  Cytomegalovirus (CMV) is a major cause of morbidity and mortality in immunocompromised patients, with CMV pneumonitis among the most severe manifestations of infection. Although bronchoalveolar lavage (BAL) samples are frequently tested for CMV, the clinical utility of such testing remains uncertain. Methods.  Retrospective analysis of adult patients undergoing BAL testing via CMV polymerase chain reaction (PCR), shell vial culture, and conventional viral culture between August 2008 and May 2011 was performed. Cytomegalovirus diagnostic methods were compared with a comprehensive definition of CMV pneumonitis that takes into account signs and symptoms, underlying host immunodeficiency, radiographic findings, and laboratory results. Results.  Seven hundred five patients underwent 1077 bronchoscopy episodes with 1090 BAL specimens sent for CMV testing. Cytomegalovirus-positive patients were more likely to be hematopoietic cell transplant recipients (26% vs 8%, P < .0001) and less likely to have an underlying condition not typically associated with lung disease (3% vs 20%, P < .0001). Histopathology was performed in only 17.3% of CMV-positive bronchoscopy episodes. When CMV diagnostic methods were evaluated against the comprehensive definition, the sensitivity and specificity of PCR, shell vial culture, and conventional culture were 91.3% and 94.6%, 54.4% and 97.4%, and 28.3% and 96.5%, respectively. Compared with culture, PCR provided significantly higher sensitivity and negative predictive value (P ≤ .001), without significantly lower positive predictive value. Cytomegalovirus quantitation did not improve test performance, resulting in a receiver operating characteristic curve with an area under the curve of 0.53. Conclusions.  Cytomegalovirus PCR combined with a comprehensive clinical definition provides a pragmatic approach for the diagnosis of CMV pneumonitis.

Indexed as

bronchoalveolar lavagecytomegalovirusdiagnosticspneumonitis

Identifiers

PMID26885542
PMCPMC4752011
OpenAlexW2301737759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.